+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of New Palladium Cages as Potential Delivery Systems for the Anticancer Drug Cisplatin

Evaluation of New Palladium Cages as Potential Delivery Systems for the Anticancer Drug Cisplatin

Chemistry 22(7): 2253-2256

Self-assembled metallocages are very promising drug-delivery systems among supramolecular complexes. Thus, exo-functionalized Pd2 L4 (L=ligand) cages were synthesized and characterized, and the encapsulation of the anticancer drug cisplatin in their cavity has been documented. The antiproliferative effects of the metallocages and their combination with cisplatin were examined in vitro in cancer cell lines, while fluorescence microscopy was used to monitor their uptake. Notably, the hydroxymethyl-functionalized Pd(II) cage encapsulating cisplatin showed improved cytotoxic effect against human ovarian cancer cells compared to free cisplatin. The toxicity of Pd2 L4 cages was evaluated for the first time ex vivo in healthy rat-liver tissues using the precision cut-tissue slices technology, demonstrating in some cases scarce effects on liver viability. These results further highlight the potential of self-assembled Pd2 L4 cages for biological applications.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 057808835

Download citation: RISBibTeXText

PMID: 26756963

DOI: 10.1002/chem.201504930

Related references

Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin. Journal of Inorganic Biochemistry 105(9): 1115-1122, 2011

Molecular simulation and in vitro evaluation of chitosan nanoparticles as drug delivery systems for the controlled release of anticancer drug cytarabine against solid tumours. 3 Biotech 8(12): 493, 2018

Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications. Archives of Pharmacal Research 41(2): 111-129, 2018

Turning Ineffective Transplatin into a Highly Potent Anticancer Drug via a Prodrug Strategy for Drug Delivery and Inhibiting Cisplatin Drug Resistance. Bioconjugate Chemistry 27(8): 1802-1806, 2016

Novel drug delivery systems: Chitosan conjugates covalently attached to steroids with potential anticancer and agrochemical activity. Carbohydrate Polymers 84(3): 858-864, 2011

Anticancer efficacy with cisplatin delivery systems. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(12): 2274-2276, 2010

Designing colon-specific delivery systems for anticancer drug-loaded nanoparticles: an evaluation of alginate carriers. Journal of Biomedical Materials Research. Part a 102(9): 3167-3176, 2014

Targeted drug delivery systems 6: Intracellular bioreductive activation, uptake and transport of an anticancer drug delivery system across intestinal Caco-2 cell monolayers. International Journal of Pharmaceutics (Kidlington) 219(1-2): 1-10, 2001

Increased Loading, Efficacy and Sustained Release of Silibinin, a Poorly Soluble Drug Using Hydrophobically-Modified Chitosan Nanoparticles for Enhanced Delivery of Anticancer Drug Delivery Systems. Nanomaterials 7(11):, 2017

Redox-responsive cisplatin nanogels for anticancer drug delivery. Chemical Communications 54(60): 8367-8370, 2018

Microcalorimetric study of microemulsions as potential drug delivery systems i. evaluation of enthalpy in the absence of any drug. International Journal of Pharmaceutics 42(1-3): 19-26, 1988

Novel micelles from graft polyphosphazenes as potential anti-cancer drug delivery systems: drug encapsulation and in vitro evaluation. International Journal of Pharmaceutics 373(1-2): 133-140, 2009

Synthesis, Anticancer Evaluation and Synergistic Effects with cisplatin of Novel Palladium Complexes: DNA, BSA Interactions and Molecular Docking Study. Medicinal Chemistry ) 2019:, 2019

Oral delivery of anticancer drugs III: formulation using drug delivery systems. DrugDiscoveryToday18(1-2):99, 2013

Evaluation of the potential for injury with remote drug-delivery systems. Wildlife Society Bulletin 34(3): 741-749, 2006